Udg Healthcare’s (UDG) Hold Rating Reiterated at Jefferies Group
Jefferies Group reiterated their hold rating on shares of Udg Healthcare (LON:UDG) in a research note released on Wednesday. Jefferies Group currently has a GBX 820 ($11.12) price target on the stock.
A number of other equities research analysts have also recently commented on the company. Peel Hunt reiterated an add rating and issued a GBX 880 ($11.93) price target on shares of Udg Healthcare in a research note on Tuesday, December 19th. Stifel Nicolaus reiterated a hold rating and issued a GBX 815 ($11.05) price target on shares of Udg Healthcare in a research note on Thursday, November 30th. Liberum Capital restated a hold rating and issued a GBX 884 ($11.99) price objective on shares of Udg Healthcare in a research note on Tuesday, November 28th. N+1 Singer restated a hold rating on shares of Udg Healthcare in a research note on Tuesday, November 28th. Finally, Numis Securities cut Udg Healthcare to a reduce rating and set a GBX 765 ($10.37) price objective for the company. in a research note on Thursday, November 9th. One investment analyst has rated the stock with a sell rating and six have given a hold rating to the company. The stock has an average rating of Hold and a consensus price target of GBX 829.29 ($11.25).
Shares of Udg Healthcare (LON UDG) opened at GBX 794 ($10.77) on Wednesday. Udg Healthcare has a 12 month low of GBX 632.50 ($8.58) and a 12 month high of GBX 963 ($13.06). The company has a market capitalization of $1,970.00 and a PE ratio of 3,780.95.
COPYRIGHT VIOLATION WARNING: “Udg Healthcare’s (UDG) Hold Rating Reiterated at Jefferies Group” was originally posted by Watch List News and is the property of of Watch List News. If you are viewing this report on another domain, it was stolen and republished in violation of US & international copyright and trademark laws. The correct version of this report can be accessed at https://www.watchlistnews.com/udg-healthcares-udg-hold-rating-reiterated-at-jefferies-group/1816938.html.
Udg Healthcare Company Profile
UDG Healthcare PLC, formerly United Drug PLC, provides advisory, commercial, clinical, communications and packaging services to the healthcare industry with operations in approximately 24 countries and delivering services in over 50 countries. The Company operates across three divisions: Ashfield, which provides commercialization services for the pharmaceutical and healthcare industry and operates across two areas of activity: advisory & communications services and commercial & clinical services and provides healthcare communications, patient support, audit, advisory, medical information and event management services; Sharp, which provides contract commercial packaging and clinical trial packaging services for the pharmaceutical and biotechnology industries and operates facilities in the United States and Europe; and Aquilant, which provides outsourced sales, marketing, distribution and engineering services to the medical and scientific sectors in the UK, Ireland and the Netherlands.
Receive News & Ratings for Udg Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Udg Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.